PRESENTATION AND WORKSHOP HIGHLIGHTS

JERRI BARDEN PERKINS, M.D.
8806 Liberty Lane
Potomac, Maryland 20854
(301) 983-0395

PRESENTATION AND WORKSHOP HIGHLIGHTS

1991- 2002 Management Forum, London, England; Clinical study requirements for FDA

1999-2001 ACRP Annual Meetings; Presentations on Preparing for an FDA Inspection

1999-2001 Management Forum, London, England; FDA Pediatric rule

1999 DIA Annual Meeting in Baltimore, MD; Presentation on Pre-FDA Audits

1995 PDA invited speaker, Rockville, MD

1994 Speaker at the state Pharmaceutical Administration of China (SPAC) and the Department of Science and Technology for Social Development, the state Science and Technology Commission of the PRC; On the topic of FDA requirements for marketing drug and medical devices in the US

1993 IX International Conference on AIDS, Berlin, Germany, "Compliance Rate for Universal Precautions Among Non-Professional and Professional Health Care Workers in a Free Clinic in Washington, D.C." Perkins, J., Grandin, J. and Korniewicz, D.

1992 Johns Hopkins Univ. School of Nursing Guest lecturer on "Barrier Protection."

1992 DIA, "Overview of FDA Clinical Trial Regulations," Philadelphia, PA

1992 "Making Effective FDA Medical Device Submission,"Barnett International, Washington, D.C.

1991 Speaker at FDA/DSMA Design and Clinical Validation of Medical Devices, Boston, MA

1987-92 RAPS (Regulatory Affairs Professional Society)
--Speaker on "Advertising Regulations," Chicago (March1992) and Newport Beach, CA (Sept.1992)
--Chaired 1990 Meeting, "Clinical Studies: How to Successfully Resolve Clinical Problems to Achieve FDA Approval," with presentation on a Case Study Analysis
--Co-chaired 1989 conference in San Diego on theme "How to Prepare for and Conduct a Clinical Investigation: Drug and Device Requirements" with presentation on Study, Implementation, Monitoring, Evaluation and Presentation to the Agency
--Initiated Clinical Program (1987) and chaired first program 1988)

1988 HIMA representative who testified at the Assembly Health Committee of the State of California on Prophylactics Bill.

E-Mail Us!

WHO ARE WE?	OUR CAPABILITIES	DRUG & DEVICE EXPERIENCE	PUBLICATIONS	CLINICAL AUDIT EXPERIENCE	HOME

1991- 2002	Management Forum, London, England; Clinical study requirements for FDA
1999-2001	ACRP Annual Meetings; Presentations on Preparing for an FDA Inspection
1999-2001	Management Forum, London, England; FDA Pediatric rule
1999	DIA Annual Meeting in Baltimore, MD; Presentation on Pre-FDA Audits
1995	PDA invited speaker, Rockville, MD
1994	Speaker at the state Pharmaceutical Administration of China (SPAC) and the Department of Science and Technology for Social Development, the state Science and Technology Commission of the PRC; On the topic of FDA requirements for marketing drug and medical devices in the US
1993	IX International Conference on AIDS, Berlin, Germany, "Compliance Rate for Universal Precautions Among Non-Professional and Professional Health Care Workers in a Free Clinic in Washington, D.C." Perkins, J., Grandin, J. and Korniewicz, D.
1992	Johns Hopkins Univ. School of Nursing Guest lecturer on "Barrier Protection."
1992	DIA, "Overview of FDA Clinical Trial Regulations," Philadelphia, PA
1992	"Making Effective FDA Medical Device Submission,"Barnett International, Washington, D.C.
1991	Speaker at FDA/DSMA Design and Clinical Validation of Medical Devices, Boston, MA
1987-92	RAPS (Regulatory Affairs Professional Society) --Speaker on "Advertising Regulations," Chicago (March1992) and Newport Beach, CA (Sept.1992) --Chaired 1990 Meeting, "Clinical Studies: How to Successfully Resolve Clinical Problems to Achieve FDA Approval," with presentation on a Case Study Analysis --Co-chaired 1989 conference in San Diego on theme "How to Prepare for and Conduct a Clinical Investigation: Drug and Device Requirements" with presentation on Study, Implementation, Monitoring, Evaluation and Presentation to the Agency --Initiated Clinical Program (1987) and chaired first program 1988)
1988	HIMA representative who testified at the Assembly Health Committee of the State of California on Prophylactics Bill.